Teva Pharmaceutical Industries Limited - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
TEVA New York 2834 www.tevapharm.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Teva Pharmaceutical Industries Limited

Teva Seeks FDA Nod for Ecopipam in Pediatric Tourette Syndrome - Jun 19th, 2026 7:16 am
Teva Just Delivered More Good News on Its Biggest Growth Driver. Is the Stock Still a Bargain? - Jun 19th, 2026 6:56 am
J&J Stock Down 3% in 3 Months: Is the Dip a Buying Opportunity? - Jun 19th, 2026 6:07 am
FDA Seeks Updated Labeling for Testosterone Therapies - Jun 18th, 2026 3:56 pm
Teva Releases Q2 2026 Aide Memoire - Jun 18th, 2026 3:00 pm
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome - Jun 18th, 2026 2:57 pm
Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET - Jun 18th, 2026 2:30 pm
Vedana debuts with $46m to progress migraine therapies - Jun 17th, 2026 10:39 am
Medincell SA (STU:MEB) Full Year 2026 Earnings Call Highlights: Strategic Growth and Challenges - Jun 16th, 2026 7:00 pm
Medincell Reports FY 2025-26 Annual Results - Jun 16th, 2026 9:45 am
Teva Refocuses On Higher‑Margin Drugs With Emalex Deal And API Cuts - Jun 13th, 2026 5:14 pm
Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock? - Jun 12th, 2026 2:25 pm
Paragon Advances Registration-Ready CNS Asset Addressing Important Unmet Need and Closes Sale to Teva Pharmaceutical - Jun 11th, 2026 1:03 pm
Alvotech Hits Critical Inflection as Biosimilar Pipeline Nears FDA Decisions - Jun 10th, 2026 1:02 pm
Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy - Jun 10th, 2026 10:03 am
Is Amneal a Buy Before Rytary Generic Erosion? - Jun 9th, 2026 9:56 am
[Latest] Global Generic Drug Market Size/Share Worth USD 926.54 Billion by 2034 at a 6.55% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) - Jun 8th, 2026 10:30 pm
Teva’s Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Highlight Long-Term Advances in Tardive Dyskinesia Treatment and Care - Jun 8th, 2026 6:00 am
Will UroGen’s Jelmyto Generic Deal with Teva Redefine UroGen Pharma's (URGN) Narrative? - Jun 8th, 2026 4:06 am
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio® - Jun 8th, 2026 2:00 am